salicylic acid has been researched along with Acute Coronary Syndrome in 3 studies
Scalp: The outer covering of the calvaria. It is composed of several layers: SKIN; subcutaneous connective tissue; the occipitofrontal muscle which includes the tendinous galea aponeurotica; loose connective tissue; and the pericranium (the PERIOSTEUM of the SKULL).
Acute Coronary Syndrome: An episode of MYOCARDIAL ISCHEMIA that generally lasts longer than a transient anginal episode that ultimately may lead to MYOCARDIAL INFARCTION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This study evaluated the association among the plasma concentration of ticagrelor, ARC124910XX, aspirin, and salicylic acid with the risk of recent bleeding in patients with the acute coronary syndrome." | 8.31 | The Plasma Concentration of Ticagrelor and Aspirin as a Predictor of Bleeding Complications in Chinese Acute Coronary Syndrome Patients With Dual Antiplatelet Therapy: A Prospective Observational Study. ( Guo, BY; Hao, J; Liu, JM; Ren, JL; Sun, YQ; Wang, CC; Yang, XL; Zhang, XR; Zhao, JJ; Zhao, Q, 2023) |
| "This study evaluated the association among the plasma concentration of ticagrelor, ARC124910XX, aspirin, and salicylic acid with the risk of recent bleeding in patients with the acute coronary syndrome." | 4.31 | The Plasma Concentration of Ticagrelor and Aspirin as a Predictor of Bleeding Complications in Chinese Acute Coronary Syndrome Patients With Dual Antiplatelet Therapy: A Prospective Observational Study. ( Guo, BY; Hao, J; Liu, JM; Ren, JL; Sun, YQ; Wang, CC; Yang, XL; Zhang, XR; Zhao, JJ; Zhao, Q, 2023) |
| "Acetylsalicylic acid (ASA) and clopidogrel combined therapy has been reported to be beneficial in patients with acute coronary syndrome (ACS)." | 3.85 | ABCC3 Polymorphisms and mRNA Expression Influence the Concentration of a Carboxylic Acid Metabolite in Patients on Clopidogrel and Aspirin Therapy. ( Bortolin, RH; Bravo, M; Brion, M; Carracedo, A; Concheiro, M; Cruz, A; Germano, JF; Hirata, MH; Hirata, RD; Iñiguez, A; López-Rivadulla, M; Luchessi, AD; Quintela, O; Silbiger, VN; Sousa, AG, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Araiza-Garaygordobil, D | 1 |
| Gopar-Nieto, R | 1 |
| Sierra-Lara Martínez, D | 1 |
| Belderrain-Morales, N | 1 |
| Sarabia-Chao, V | 1 |
| Alfaro-Ponce, DL | 1 |
| Ontiveros-Mercado, H | 1 |
| Mendoza-García, S | 1 |
| Altamirano-Castillo, A | 1 |
| Martinez-Amezcua, P | 1 |
| Cabello-López, A | 1 |
| Briseño-De la Cruz, JL | 1 |
| Ruiz-Beltrán, M | 1 |
| Martínez-Ríos, MA | 1 |
| Piña-Reyna, Y | 1 |
| Gonzalez-Pacheco, H | 1 |
| Arias-Mendoza, A | 1 |
| Wang, CC | 1 |
| Zhao, Q | 1 |
| Guo, BY | 1 |
| Hao, J | 1 |
| Zhao, JJ | 1 |
| Ren, JL | 1 |
| Sun, YQ | 1 |
| Zhang, XR | 1 |
| Yang, XL | 1 |
| Liu, JM | 1 |
| Luchessi, AD | 1 |
| Concheiro, M | 1 |
| Germano, JF | 1 |
| Silbiger, VN | 1 |
| Bortolin, RH | 1 |
| Cruz, A | 1 |
| Quintela, O | 1 |
| Brion, M | 1 |
| Carracedo, A | 1 |
| Iñiguez, A | 1 |
| Bravo, M | 1 |
| López-Rivadulla, M | 1 |
| Hirata, RD | 1 |
| Sousa, AG | 1 |
| Hirata, MH | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Randomized Controlled Trial of Dual Antiplatelet Therapy Versus Antiplatelet Monotherapy and Oral Anticoagulation in Patients With Acute Coronary Syndrome and Coronary Artery Ectasia: OVER-TIME[NCT05233124] | Phase 2 | 60 participants (Anticipated) | Interventional | 2021-09-01 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for salicylic acid and Acute Coronary Syndrome
| Article | Year |
|---|---|
Dual Antiplatelet Therapy Versus Antiplatelet Monotherapy Plus Oral Anticoagulation in Patients with Acute Coronary Syndrome and Coronary Artery Ectasia: Design and Rationale of OVER-TIME Randomized Clinical Trial.
Topics: Acute Coronary Syndrome; Anticoagulants; Coronary Vessels; Dilatation, Pathologic; Drug Therapy, Com | 2022 |
2 other studies available for salicylic acid and Acute Coronary Syndrome
| Article | Year |
|---|---|
The Plasma Concentration of Ticagrelor and Aspirin as a Predictor of Bleeding Complications in Chinese Acute Coronary Syndrome Patients With Dual Antiplatelet Therapy: A Prospective Observational Study.
Topics: Acute Coronary Syndrome; Aspirin; East Asian People; Hemorrhage; Humans; Percutaneous Coronary Inter | 2023 |
ABCC3 Polymorphisms and mRNA Expression Influence the Concentration of a Carboxylic Acid Metabolite in Patients on Clopidogrel and Aspirin Therapy.
Topics: Acute Coronary Syndrome; Aged; Aspirin; Carboxylic Acids; Chromatography, Liquid; Clopidogrel; Cytoc | 2017 |